Volume 20 - Issue 7 - July 2007
Given the severe ramifications associated with the combination of critical limb ischemia (CLI) and diabetic foot ulcers, this author emphasizes the potential impact of revascularization procedures in reducing the number of lower extremity ampulations. Accordingly, he offers a closer looks at recent advances in this arena and their place within the armentarium for CLI
It has been estimated that a person with diabetes has a 25 percent lifetime risk of developing a foot ulceration.1 Diabetic foot ulcers commonly become infected, can involve bones and joints and may progress to amputation. Osteomyelitis frequently complicates ulcerations in people with diabetes and may be present in up to 20 percent of mild to moderate and 50 to 60 percent of severely infected wounds.2
Continuing Education » MRSA
Given the increasing prevalence of methicillin resistant Staphylococcus aureus (MRSA), these authors discuss the differences between HA-MRSA and CA-MRSA, what the literature reveals about antibiotic therapy and keys to the diagnostic workup of these patients.
Vacuum Assisted Closure (VAC, KCI) may be the most impressive device for the foot since AO fixation revolutionized elective foot surgery. For large or difficult wounds, VAC therapy can rapidly improve granulation tissue and speed up coverage of exposed tendon and bones. Indeed, this often occurs in days to weeks rather than months. Most clinicians are convinced at the bedside when they see dramatic changes in the characteristics of a wound such as size, depth and exposed structures.
There is a growing body of evidence that supports the clinical observations and animal research that have be
- « Previous
- | Page 1 of 3 |
- Next »